Cannabis Market Expands Globally

NEW YORK, March 2, 2017 /PRNewswire/ --

The global medical cannabis market size was valued at USD 11.4 billion in 2015 and is projected to grow with CAGR of 17.1% during the forecast period, USD 55.8 billion by 2025, according to Grand View Research. The market is experiencing growth due to rising awareness regarding various medical applications such as pain management, appetite enhancement, and reducing eye pressure, as well as due to an increasing number of countries around the world allowing cannabis products to be manufactured and sold. NutraFuels Inc. (OTC: NTFU), American Cannabis Company Inc. (OTC: AMMJ), Growblox Sciences Inc. (OTC: GBLX), United Cannabis Corporation (OTC: CNAB) MassRoots Inc. (OTC: MSRT)

The report indicates that North America held a majority of the shares of nearly 49.0% in 2015. The surging pace of cannabis legalization in the U.S. is one of the key factors contributing to its increased demand. In the U.S., cannabis has been legalized for recreational uses in 4 states and 5 states, namely, California, Maine, Arizona, Massachusetts, and Nevada have voted for its legalization for recreation needs also. North America is also projected to be the fastest growing market with a CAGR of 22.0% during the forecast period.

NutraFuels Inc. (OTC: NTFU) is a manufacturer, distributer and marketer of a line of oral spray nutritional dietary products to consumers, retailers and wholesale outlets. Oral spray delivery systems are recognized by many as an effective methodology for delivery of pharmaceutical and nutraceutical products. On February 23^rd, the company announced that as part of the implementation of initiation of clinical studies on the company's product line of oral spray nutraceuticals has announced the appointment of Kenneth Duchin, Ph.D., as Vice-President, Clinical Development and the agreement with Palm Beach Research to conduct clinical studies.

The recent growth of NutraFuels has provided the opportunity to explore the benefits of the oral spray product line. Dr Duchin's career has spanned over 30 years in the pharmaceutical industry in various management positions at Bristol-Myers Squibb and in small and mid-size companies (Theravance, IVAX Corporation, Noven Pharmaceuticals) as well as in start-up virtual organizations. He has extensive drug development experience in a broad range of therapeutic areas, led several registration programs, authored regulatory NDA and ANDA documents and has led cross-functional development teams. In addition, he has been an inventor of 9 patents and has published nearly 40 papers in peer reviewed journals.

To facilitate the clinical investigations sponsored by Nutrafuels, the company has engaged Palm Beach Research, West Palm Beach FL to conduct the clinical studies. This facility has access to large numbers of patients who routinely participate in clinical trials for many pharmaceutical and biotech companies based in the US and abroad.

"We are very pleased to be working with Ken and Palm Beach Research to initiate clinical trials for our health and wellness products," said Edgar Ward, NutraFuels President/CEO.

American Cannabis Company Inc. (OTCQB: AMMJ) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. American Cannabis Company also developed and now owns a portfolio of branded products including: The Satchel™, SoHum Living Soils™, The Cultivation Cube™ and The High Density Cultivation System™. We also design and provide other industry-specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, 'the art and science of agriculture in soil.'

Growblox Sciences Inc. (OTCQB: GBLX) merges state-of-the-art technologies in plant biology, cultivation and post-production processes in order to optimize safe, consistent medical Cannabis. The company is pioneering technologies and industry-leading processes in combination with a Big Data-driven clinical research and development program to bring relief to patients in communities across the country. The company develops a comprehensive line of highly effective cannabis-based therapies ranging from custom medical compounds to consumer health and beauty products. The GB Sciences cultivation methodology ensures a consistent ratio of the plant's medicinal properties for each and every harvest. This is a critical factor when creating formulations for standardized therapeutic products.

United Cannabis Corporation (OTCQB: CNAB) has signed an exclusive licensing agreement with Vessel Life Sciences to produce and distribute its products, including the award-winning Prana Bio Nutrient Medicinals, throughout Pennsylvania. The Company's Prana Bio Medicinal products provide patients a simple, safe, accurate and easy way to mix-match cannabinoids for therapeutic purpose. These products are broken into 5 easy-to-use categories that are available in capsules, sublinguals and topical delivery methods. The company uses a patent-pending infusion process utilizing select fatty acids, lipids and specific combination of cannabis derived terpenes to increase bioavailability. Prana Bio Medicinal products are NON-GMO, ethanol-free, alcohol-free, glycerin-free, gluten-free, 100% naturally derived, chemical-free, solventless and hypoallergenic.

MassRoots Inc. (OTCQB: MSRT) is one of the largest technology platforms for the regulated cannabis industry. The Company's mobile apps enable consumers to make medical cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. MassRoots is not associated with the production or sale of cannabis, rather the company is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over 900,000 registered users.

Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com    

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. Financialbuzz.com has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. FinancialBuzz.com only regurgitates financial or corporate news through our unique financial newswire and media platform. FinancialBuzz.com has been compensated a total of ten thousand dollars for financial news dissemination and PR services by a third-party non-affiliate for Nutrafuels Inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information:
Media Contact:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com